Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
blinatumomab
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
blinatumomab
Unique ID
C510808
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C510808
Entry Term(s)
Blincyto
MEDI-538
MT-103 antibody
antibody MT-103
Pharm Action
Antineoplastic Agents
Registry Numbers
4FR53SIF3A
0
Heading Mapped to
*Antibodies, Bispecific
Frequency
386
Note
a single-chain bispecific recombinant antibody from Micromet's BiTE (bispecific T-cell engager) product platform that binds both the CD19 antigen and the T-cell receptor (CD3), for the potential treatment of B-cell lymphoma
Source
Curr Opin Mol Ther 2006 Feb;8(1):62-8
Date of Entry
2006/06/08
Revision Date
2019/10/31
Expand All
Collapse All
blinatumomab
Preferred
Concept UI
M0498704
Registry Numbers
4FR53SIF3A
Terms
blinatumomab
Preferred Term
Term UI
T724484
Date
08/26/2008
LexicalTag
NON
ThesaurusID
Blincyto
Narrower
Concept UI
M000603322
Registry Numbers
0
Terms
Blincyto
Preferred Term
Term UI
T000876662
Date
03/11/2015
LexicalTag
TRD
ThesaurusID
NLM (2015)
MT-103 antibody
Narrower
Concept UI
M000618058
Terms
MT-103 antibody
Preferred Term
Term UI
T675543
Date
06/08/2006
LexicalTag
LAB
ThesaurusID
NLM (2006)
antibody MT-103
Term UI
T675544
Date
06/08/2006
LexicalTag
NON
ThesaurusID
NLM (2006)
MEDI-538
Narrower
Concept UI
M000654723
Terms
MEDI-538
Preferred Term
Term UI
T000966286
Date
08/22/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
page delivered in 0.003s
